Literature DB >> 20233172

Editors' pick 2009.

A Somogyi, Y K Loke, A Ferro, L D Lewis, A F Cohen, J M Ritter.   

Abstract

Mesh：

Year:  2010        PMID： 20233172      PMCID： PMC2824470          DOI： 10.1111/j.1365-2125.2009.03606.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  21 in total

1.  A new colonialism?--Conducting clinical trials in India.

Authors:  Samiran Nundy; Chandra M Gulhati
Journal:  N Engl J Med       Date:  2005-04-21       Impact factor: 91.245

Review 2.  Nanotechnologies and controlled release systems for the delivery of antisense oligonucleotides and small interfering RNA.

Authors:  Elias Fattal; Gillian Barratt
Journal:  Br J Pharmacol       Date:  2009-04-02       Impact factor: 8.739

3.  Looking back: editors' pick of 2008.

Authors:  Y K Loke; A Somogyi; L D Lewis; M Schachter; A F Cohen; J M Ritter
Journal:  Br J Clin Pharmacol       Date:  2009-01       Impact factor: 4.335

4.  Investigator-initiated pragmatic trials in developing countries--much needed but much ignored.

Authors:  Nusrat Shafiq; Promila Pandhi; Samir Malhotra
Journal:  Br J Clin Pharmacol       Date:  2008-11-03       Impact factor: 4.335

5.  Effects of Schisandra sphenanthera extract on the pharmacokinetics of midazolam in healthy volunteers.

Authors:  Hua-Wen Xin; Xiao-Chun Wu; Qing Li; Ai-Rong Yu; Lei Xiong
Journal:  Br J Clin Pharmacol       Date:  2009-02-04       Impact factor: 4.335

6.  The impact of clinical trials legislation on clinical pharmacology: problems and solutions.

Authors:  Morris J Brown
Journal:  Br J Clin Pharmacol       Date:  2009-02-02       Impact factor: 4.335

7.  Informed consent document improvement does not increase patients' comprehension in biomedical research.

Authors:  Adeline Paris; Christian Brandt; Catherine Cornu; Patrick Maison; Claire Thalamas; Jean-Luc Cracowski
Journal:  Br J Clin Pharmacol       Date:  2010-03       Impact factor: 4.335

Review 8.  Biomarkers for the effects of cannabis and THC in healthy volunteers.

Authors:  Lineke Zuurman; Annelies E Ippel; Eduard Moin; Joop M A van Gerven
Journal:  Br J Clin Pharmacol       Date:  2009-01       Impact factor: 4.335

Review 9.  The clinical pharmacology of therapeutic monoclonal antibodies in the treatment of malignancy; have the magic bullets arrived?

Authors:  Barrett W Newsome; Marc S Ernstoff
Journal:  Br J Clin Pharmacol       Date:  2008-05-22       Impact factor: 4.335

10.  Tolerability and safety of GS-101 eye drops, an antisense oligonucleotide to insulin receptor substrate-1: a 'first in man' phase I investigation.

Authors:  Hermann Kain; David Goldblum; Bernard Geudelin; Eric Thorin; Christoph Beglinger
Journal:  Br J Clin Pharmacol       Date:  2009-08       Impact factor: 4.335
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.